Status:
COMPLETED
Adolescent and Child Suicide Prevention in Routine Clinical Encounters
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
University of Pennsylvania
National Institute of Mental Health (NIMH)
Conditions:
Suicide
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to compare two approaches to implement an evidence-based firearm safety promotion program, S.A.F.E. Firearm, in pediatric primary care as a universal suicide prevention ...
Detailed Description
The investigators will conduct a hybrid type III effectiveness-implementation trial using a longitudinal cluster randomized design to test the most effective way to implement S.A.F.E. Firearm among 30...
Eligibility Criteria
Inclusion
- Parents
- Parents and/or legal guardians (hereafter referred to as parents) at participating pediatric clinics who have a child age 5-17 who attends a well visit. At least one parent must attend the well visit to be eligible. The parent must be at least 18 years old to participate.
Exclusion
- Parents
- Due to translation costs and challenges of recruiting non-US resident participants, respectively, non-English speaking parents and non-US resident parents will not be eligible to participate at Henry Ford Health System.
- Inclusion Criteria: Clinicians and leaders
- Pediatric physicians and non-physician clinicians (hereafter referred to as clinicians) employed within the participating pediatric clinics, as well as health system leaders employed within the two health systems, are eligible to participate. Family medicine clinicians who see pediatric patients in participating clinics at Kaiser Permanente Colorado will also be eligible.
- Exclusion criteria: Clinicians and leaders
- At Kaiser Permanente Colorado, family medicine clinicians whose patient panel is comprised of fewer than 5% pediatric patients will be excluded.
- Family medicine clinicians who see pediatric patients in participating clinics at Henry Ford Health System will be excluded.
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 8 2024
Estimated Enrollment :
47307 Patients enrolled
Trial Details
Trial ID
NCT04844021
Start Date
March 14 2022
End Date
May 8 2024
Last Update
July 25 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Colorado
Aurora, Colorado, United States, 80014
2
Henry Ford Health System
Detroit, Michigan, United States, 48202